GlassScriptPhysician profile
Oliver Batiste
NPI 1104321686
$1,974.41
in general payments reported to CMS, 2019-2025
25 companies · $166 in 2025
The $166 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $359 · 2023: $665 · 2024: $785 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,615.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,615.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $216.36 | 2022-2025 | Phexxi, Solosec, Phexx |
| Medtronic, INC. | $201.30 | 2022-2024 | V-Loc 180, Situate, Interstim |
| Organon LLC | $191.12 | 2024 | |
| Mayne Pharma Commercial LLC | $159.20 | 2022-2024 | |
| Biogen, INC. | $133.40 | 2024-2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $130.97 | 2022-2023 | |
| Sumitomo Pharma America, INC. | $129.68 | 2023-2025 | Myfembree |
| Gynesonics, INC. | $112.16 | 2023-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Hologic Sales and Service, LLC | $95.21 | 2023-2024 | Novasure, Fluent Fluid Management System, Myosure Tissue Removal Device |
| Exeltis, USA INC. | $73.93 | 2023-2025 | Slynd |
| Millicent US INC | $70.25 | 2023-2025 | Intrarosa, Femring |
| Pfizer INC. | $65.11 | 2022-2024 | |
| Abbvie INC. | $63.70 | 2023-2024 | Lo Loestrin Fe, Liletta |
| Myovant Sciences INC. | $47.96 | 2022 | |
| Coopersurgical, INC. | $46.57 | 2022-2024 | Paragard T 380a |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $45.11 | 2022 | |
| Smith+Nephew, INC. | $37.49 | 2022 | |
| Exact Sciences Corporation | $21.68 | 2024 | Cologuard Collection Kit |
| Ethicon US, LLC | $20.33 | 2025 | Surgiflo Hemostatic Matrix, Dermabond, Ethicon |
| Mylan Pharmaceuticals INC. | $20.11 | 2022 | |
| Astellas Pharma US INC | $19.64 | 2024 | Veozah |
| Abbott Laboratories | $19.62 | 2024 | Proclaim |
| Aspira Women'S Health INC | $17.87 | 2024 | Ova1 |
| Merck Sharp & Dohme LLC | $17.82 | 2022 | |
| Mission Pharmacal Company | $17.82 | 2023 | Citranatal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Oliver Batiste listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.